Search - tctmd.com

Displaying 261 - 280 of 2580

Sort: Relevancy | Date

News Daily News

La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro

Yael L. Maxwell

September 14, 2016

News Daily News

Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry

Yael L. Maxwell

September 14, 2016

News Daily News

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

Shelley Wood

September 13, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

News Daily News

Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas

Shelley Wood

September 13, 2016

Presentation

Association Between TAVR and Subsequent Infective Endocarditis (IE) and In-hospital Death

Presenter: Ander Regueiro

September 13, 2016

Presentation

Timing, Risk Factors, Outcomes of Stroke, TIA after TAVR: PARTNER Trial

Presenter: Samir Kapadia

September 12, 2016

Presentation

Neurological Events Following TAVR and Their Predictors: CoreValve Trials

Presenter: Neal Kleiman

September 12, 2016

News Conference News ESC 2016

Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy

Todd Neale

September 02, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

News Daily News

Mortality Risk High in TAVR Patients Who Require Mechanical Circulatory Support

Todd Neale

August 25, 2016

Presentation

Elective or Emergency Use of MechanicalCirculatory Support (MCS) Devices During TAVR

Presenter: Vikas Singh

August 25, 2016

News Daily News

较低风险患者 TAVR 后生存率优于手术组，没有“风险升高”

L.A. McKeown

August 24, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

L.A. McKeown

August 24, 2016

News Daily News

Mejor Supervivencia y Ausencia de ‘Tendencia de Riesgo’ para TAVR vs Cirugía en Pacientes de Menor Riesgo

L.A. McKeown

August 24, 2016

News Opinion Editor's Corner

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

Shelley Wood

August 24, 2016

News Daily News

Medtronic Warns of Vascular Trauma, Some Resulting in Death, With CoreValve’s EnVeo R Delivery Catheter

Michael O'Riordan

August 18, 2016

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

Presentation

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Presenter: Abdul-Jawad Altisent

August 16, 2016

Advertisement

La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro

Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas

Association Between TAVR and Subsequent Infective Endocarditis (IE) and In-hospital Death

Timing, Risk Factors, Outcomes of Stroke, TIA after TAVR: PARTNER Trial

Neurological Events Following TAVR and Their Predictors: CoreValve Trials

Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy

TCTMD’s Top 10 Most Popular Stories for August 2016

Mortality Risk High in TAVR Patients Who Require Mechanical Circulatory Support

Elective or Emergency Use of MechanicalCirculatory Support (MCS) Devices During TAVR

较低风险患者 TAVR 后生存率优于手术组，没有“风险升高”

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

Mejor Supervivencia y Ausencia de ‘Tendencia de Riesgo’ para TAVR vs Cirugía en Pacientes de Menor Riesgo

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

Medtronic Warns of Vascular Trauma, Some Resulting in Death, With CoreValve’s EnVeo R Delivery Catheter

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content